Anti-aging pills are no longer drugs of the future--the first trial in people could begin as early as next year. Last month, the scientists behind the trial began talks with the US Food and Drug Administration to hammer out the practicalities. The trial aims to test whether a diabetes drug called metformin also delays death and age-related conditions such as heart disease, cancer and mental decline.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados